Home
 /
Papers
 /
Biochemistry
 /
UBE3C retrofits the proteasome to enforce degradation of ultra-stable folds
Preprint
Open access
V1
Top 1% · Validated by QED

UBE3C retrofits the proteasome to enforce degradation of ultra-stable folds

Shitao Zou, Deyao Yin, Miyun Shi +9 more
March 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2026.02.24.707655
94
%
Reproducible
QED Impressions
This paper passed independent validation.
QED's automated review checked the evidence supporting each claim, the statistical methods, and whether the results are reproducible from the data provided.

It ranks in the top 1% of preprints assessed in Biochemistry this quarter.
Run full QED analysis
Read paper
Save

Why this is interesting

Defining the complete UBE3C-proteasome structural cycle, this work reveals how a single E3 ligase overrides USP14, branches ubiquitin chains, and amplifies unfolding forces to clear aggregates that otherwise evade degradation—unlocking therapeutic targets for neurodegeneration.

QED claims analysis

Summary

UBE3C retrofits the 26S proteasome to enforce degradation of ultra-stable protein folds through three integrated mechanisms: binding to a cryptic lid receptor site and synthesizing branched ubiquitin chains via four linkage-specific sites on its HECT domain to enhance substrate affinity, creating an extreme shortcut for ubiquitin delivery that bypasses the deubiquitylase USP14 and promotes its recycling, and allosterically strengthening AAA-ATPase unfoldase activity by 30-50% to overcome the high unfolding energy barriers of proteotoxic aggregation-prone substrates.

See full analysis
Main Claim 1 –

UBE3C Enables Proteasomal Degradation of Ultra-Stable Protein Folds

Main Claim 2 –

Proteasome-Bound UBE3C Cycles Through P1–P4 Conformations

Supporting evidence

  • UBE3C State Populations Shift Over Time with P4 Enrichment
  • UBE3C HECT Domain Rotates 22° During P1–P4 Transition
Main Claim 3 –

UBE3C N-Terminus Inserts into Cryptic Proteasome Lid Receptor

Supporting evidence

  • Calmodulin–IQ Motif Binding Stabilizes UBE3C and Tunes Association
  • Calmodulin Co-Purifies with UBE3C and Prevents Aggregation
  • UBE3C Colocalizes with Proteasome and Calmodulin in Cells
Main Claim 4 –

UBE3C HECT A/D/E/X Sites Drive Branched Ubiquitin Chains

Supporting evidence

  • E-Site Mutations Preferentially Disrupt K29/K33 Ubiquitin Linkages

Abstract

Neurodegeneration and proteinopathies arise from mutated or misfolded proteins that form ultra-stable, proteotoxic aggregates that evade proteasomal degradation despite ubiquitylation. These conditions are exacerbated by the deubiquitylase USP14 that can prematurely rescue substrates. To counter these obstacles to effective proteolysis, eukaryotes evolved the highly conserved HECT-type E3 ligase UBE3C—dysregulated in neurodegeneration and overexpressed in cancers—to reprogram the 26S proteasome toward heightened activity via unknown mechanisms. Here we visualized functional dynamics of the human UBE3C-retrofitted proteasome enforcing degradation of a re-engineered superfolder GFP that normally escapes proteolysis, using time-resolved cryo-electron microscopy. A continuum of non-equilibrium conformations, comprising fourteen proteasome conformers orthogonally combined with four UBE3C states or three USP14 states, reveals a cryptic UBE3C-receptor site in the proteasomal lid and captures key intermediates of ubiquitin-chain elongation and branching at four linkage-specific ubiquitin-binding sites. Remarkably, UBE3C creates an extreme shortcut for ubiquitin shuttling that bypasses USP14, promotes USP14 recycling and allosterically strengthens substrate-unfolding forces of the AAA-ATPase unfoldase to ultimately surmount the unfolding energy barrier of ultra-stable proteins. These findings define the complete functional cycle of the UBE3C-reprogrammed proteasome, illuminating how UBE3C simultaneously controls USP14 and the proteasome to enforce clearance of ultra-stable folds, and establish crucial mechanistic foundations for proteolysis-targeting therapeutic discovery.

Related papers

How the QED Score works

QED Score is a validated AI-based quality metric that evaluates life science papers on two dimensions: originality and validity. Each manuscript is anonymized, broken down into its claims and supporting evidence, and examined by specialized AI agents for statistical rigor, consistency across figures, and fit with the existing literature. Scores are percentile ranks, so they're comparable across fields. In blinded tests, expert professors sided with QED Score over journal rank in 75% of decisive cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?